# Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

> **NCT06510699** · PHASE2 · RECRUITING · sponsor: **The University of Queensland** · enrollment: 104 (estimated)

## Conditions studied

- Fungal Infection
- Haematological Malignancy
- Blood Cancer
- Infectious Disease

## Interventions

- **OTHER:** genotype-directed dosing with dosing software based on therapeutic drug monitoring

## Key facts

- **NCT ID:** NCT06510699
- **Lead sponsor:** The University of Queensland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-14
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-03-26
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06510699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06510699, "Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06510699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*